Page 20 - Pharma

Cadila Healthcare receives US FDA's EIR report for Ahmedabad facility

The company has received an Establishment Inspection Report (EIR) from the US drug regulator for its topical manufacturing facility located at Changodar (Ahmedabad)

GST prompts a change in business model

Goods and Services Tax (GST) can be a game-changer that propels India into the big league of developed nations, says Mamta Binani

Cipla names Umang Vohra as MD & Global CEO

The current incumbent, Subhanu Saxena will step down from his position on August 31, 2016. The company also announced that Samina Vaziralli will become executive vice-chairman

Lupin receives US FDA for electrolyte replenisher

The approved product, potassium chloride extended-release tablet, is a generic version of Upsher-Smith Labs' Klor-Con tablet

Sun Pharma extends patient support program for cancer drug in US

Started as part of the imatinib mesylate launch in February 2016, the program is aimed at delivering greater access to the drug to patients

SRF to invest Rs 345 crore in two chemical plants

It will spend Rs 165 crore and Rs 180 crore at its Dahej manufacturing site for setting up chloromethane and specialty chemicals plants, respectively

Teva acquires US-based drug distributor Anda for $ 500 mn

Acquisition of Anda Inc, the fourth largest distributor of generic pharmaceuticals in the US, will significantly strengthen Teva's extensive supply chain network in the US

Natco Pharma receives US FDA approval for generic Tamiflu capsules

Tamiflu oral capsules (Roche's trade name for oseltamivir phosphate) had US sales of about $ 403 million for twelve months ending December 2015, according to IMS Health

Dr Reddy's completes acquisition of product portfolio from Teva

The combined sales of the branded versions of these products in the US is about $ 3.5 billion MAT for the most recent twelve months ending in June 2016, according to IMS Health

Brenntag to invest GBP 50 million in UK over 5 years

The focus will be on the life science sector, especially the food as well as the pharmaceutical and cosmetics sectors

Aurobindo Pharma receives US FDA nod for anti-infective drug

The approved product, linezolid injection 600 mg/300 mL (2 mg/mL), has an estimated market size of $ 87 million for the twelve months ending June 2016, according to IMS

Zydus acquires derma brand Melgain from Issar Pharma

With the acquisition of Melgain, used for the treatment of vitiligo, Zydus will strengthen its position in the Rs 6000 crore dermatology market

Sun Pharma receives US FDA nod for diabetes drug metformin ER tablets

These tablets, which are generic versions of Glumetza, have annual sales of approximately $ 1.2 billion in the US, according to IMS Health

Lupin acquires 21 branded products from Japan's Shionogi for $ 150 mn

These 21 products, covering therapy areas such as central nervous system (CNS), oncology, cardiovascular and anti-infectives, had sales of Yen 9.4 bn ($ 90 million) collectively

Alphabet arm Verily to collaborate with GSK for bioelectronic medicines

Both companies will invest up to Pound 540 million (about $ 710 million) in the joint venture Galvani Bioelectronics, which will be headquartered in the UK

Suven receives patents for CNS drug in Macau and New Zealand

These patents are valid through 2032

Borosil Glass buys 60% stake in glass packaging company Klasspack

With this, Borosil has entered into primary pharma glass packaging business

Ajanta Pharma receives US FDA approval for heartburn drug

The approved product, omeprazole and sodium bicarbonate powder for oral suspension, is a bioequivalent generic version of Salix Pharmaceuticals' Zegerid powder

China's Fosun Pharma acquires 86% stake in Gland Pharma for $ 1.26 bn

Acquisition will help Fosun Pharma to strengthen its presence in the global injectables market - one of the fastest growing segment within pharma industry

Amend Drugs and Cosmetics Act to promote e-pharmacy in India

While e-pharmacy offers convenience to people, there are concerns with respect to legitimacy of e-pharmacies, patients' safety and privacy, adverse effect on retailers business, etc